About Index Trending news
Analyze
Top 50 Pricing
Cleveland BioLabs

Cleveland BioLabs

Work at Cleveland BioLabs? Add yourself to this profile

Cleveland BioLabs

Clinical-stage biotech developing a robust pipeline of drugs for multiple medical and defense applications, with a focus on oncology and tissue protection.

Elsewhere

Alexa global traffic share

04 Feb 2015
$4,200,000
Post-IPO equity
03 Jul 2014
$3,500,000
Venture capital